179 related articles for article (PubMed ID: 18376105)
1. Characterization of pituitary cell populations in rats with induced polycystic ovaries.
Francou M; Durdos M; Salvetti NR; Baravalle C; Rey F; Ortega HH
Cells Tissues Organs; 2008; 188(3):310-9. PubMed ID: 18376105
[TBL] [Abstract][Full Text] [Related]
2. The effect of cold stress on polycystic ovary syndrome in rat: before and during modeling.
Zangeneh FZ; Abdollahi A; Tavassoli P; Naghizadeh MM
Arch Gynecol Obstet; 2011 Sep; 284(3):651-7. PubMed ID: 20949356
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary rat model exposure to 150 kHz intermediate frequency: hypothalamic-pituitary-ovarian axis at the receptor, cellular, tissue, and hormone levels.
Mohammed S; Sundaram V; Adidam Venkata CR; Zyuzikov N
J Ovarian Res; 2021 Dec; 14(1):173. PubMed ID: 34895279
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovarian disease: animal models.
Mahajan DK
Endocrinol Metab Clin North Am; 1988 Dec; 17(4):705-32. PubMed ID: 2973982
[TBL] [Abstract][Full Text] [Related]
5. Induction of Stein-Leventhal-like polycystic ovaries (PCO) in the rat: a new model for cystic ovarian disease.
McCarthy GF; Brawer JR
Anat Rec; 1990 Oct; 228(2):137-44. PubMed ID: 2122768
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-like immunoreactivity in lactotrophs, gonadotrophs, and somatotrophs of rat anterior pituitary gland are affected differentially by ovarian steroid hormones.
Kanyicska B; Lerant A; Freeman ME
Endocrine; 2001 Mar; 14(2):263-8. PubMed ID: 11394645
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin ovarian cell expression in patients with polycystic ovary syndrome: an immunohistochemical evaluation.
Komarowska H; Waśko R; Iwanik K; Majewski P; Rafińska L; Warenik-Szymankiewicz A; Sowiński J
Horm Metab Res; 2006 Dec; 38(12):783-8. PubMed ID: 17163351
[TBL] [Abstract][Full Text] [Related]
9. Morphometric assessment of the impact of serum thymulin immunoneutralization on pituitary cell populations in peripubertal mice.
Camihort G; Luna G; Vesenbeckh S; Ferese C; Dardenne M; Goya R; Cónsole G
Cells Tissues Organs; 2006; 184(1):23-30. PubMed ID: 17190977
[TBL] [Abstract][Full Text] [Related]
10. Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat.
Baravalle C; Salvetti NR; Mira GA; Pezzone N; Ortega HH
Arch Med Res; 2006 Oct; 37(7):830-9. PubMed ID: 16971221
[TBL] [Abstract][Full Text] [Related]
11. Occasional transsynaptic viral labeling in the central nervous system from the polycystic ovary induced by estradiol valerate.
Gerendai I; Wiesel O; Tóth IE; Boldogköi Z; Hornyák A; Halász B
Microsc Res Tech; 2005 Mar; 66(4):186-92. PubMed ID: 15889426
[TBL] [Abstract][Full Text] [Related]
12. Stress-induced activation of ovarian heat shock protein 90 in a rat model of polycystic ovary syndrome.
Park E; Cockrem JF; Han KH; Kim DH; Jung MH; Chu JP
J Obstet Gynaecol Res; 2012 Feb; 38(2):396-407. PubMed ID: 22176470
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of nuclear 3,5,3'-triiodothyronine receptor proteins in gonadotrophs and corticotrophs in rat anterior pituitary by double immunohistochemical staining.
Sasaki S; Nakamura H; Tagami T; Osamura Y; Imura H
Endocrinology; 1991 Jul; 129(1):511-6. PubMed ID: 1647308
[TBL] [Abstract][Full Text] [Related]
14. Induction of secretory leukocyte protease inhibitor (SLPI) in estradiol valerate (EV) induced polycystic ovary.
Park JJ; Bae CS; Choi BD; Jeong SJ; Wang G; Lim DS; Kim BO; Cho YS; Kim SJ; Jeong MJ
Arch Pharm Res; 2011 Aug; 34(8):1389-97. PubMed ID: 21910062
[TBL] [Abstract][Full Text] [Related]
15. Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat.
Zurvarra FM; Salvetti NR; Mason JI; Velazquez MM; Alfaro NS; Ortega HH
Reprod Fertil Dev; 2009; 21(7):827-39. PubMed ID: 19698287
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome: etiology and pathogenesis.
Matalliotakis I; Kourtis A; Koukoura O; Panidis D
Arch Gynecol Obstet; 2006 Jul; 274(4):187-97. PubMed ID: 16685527
[TBL] [Abstract][Full Text] [Related]
17. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.
Jonard S; Dewailly D
Hum Reprod Update; 2004; 10(2):107-17. PubMed ID: 15073141
[TBL] [Abstract][Full Text] [Related]
18. PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?
Doi SA; Towers PA; Scott CJ; Al-Shoumer KA
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):4-16. PubMed ID: 15596265
[TBL] [Abstract][Full Text] [Related]
19. Morphology of the pituitary gland in ferrets (Mustela putorius furo) with hyperadrenocorticism.
Schoemaker NJ; van der Hage MH; Flik G; Lumeij JT; Rijnberk A
J Comp Pathol; 2004 May; 130(4):255-65. PubMed ID: 15053928
[TBL] [Abstract][Full Text] [Related]
20. Participation of vasoactive intestinal polypeptide in ovarian steroids production during the rat estrous cycle and in the development of estradiol valerate-induced polycystic ovary.
Parra C; Fiedler JL; Luna SL; Greiner M; Padmanabhan V; Lara HE
Reproduction; 2007 Jan; 133(1):147-54. PubMed ID: 17244741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
